This information is provided by the National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD).
Psuedohypoaldosteronism type 2 is an inborn error of metabolism. It is characterized by high blood pressure, high levels of potassium in the body, and metabolic acidosis. It is caused by mutations in the WNK1 or WNK4 gene. Treatment may involve dietary restriction of sodium and hydrochlorothiazide.
For more information, visit GARD.